HCPLive

Higher Dose of Fulvestrant Associated With Improved Survival in Advanced Breast Cancer

Postmenopausal women with advanced estrogen receptor–positive breast cancer lived longer when they received a 500-mg dose of fulvestrant as compared with a 250-mg dose.

Click here to view this article.

Most Popular

Recommended Reading

High intake of fish and long-chain ω-3 polyunsaturated fatty acids (PUFAs) is associated with reduced all-cause mortality after breast cancer, according to a study published online March 24 in Cancer.

For women with early-stage breast cancer, cognitive-behavioral stress management (CBSM) delivered after surgery is associated with long-term psychological benefits, according to a study published online March 23 in Cancer.

Minority patients are less actively involved in surgeon and hospital selection for breast cancer surgery, according to a study published online March 19 in JAMA Oncology.

Patients with low-risk prostate or breast cancer may have higher or lower odds of getting an unnecessary imaging based on geography, according to a new study published online March 12 in JAMA Oncology.
$vAR$